NCLT okays merger of Monsanto India with Germany's Bayer CropScience

Bayer Group is present in India since 1896 and has two divisions -- crop science and pharmaceutical. It has one listed entity in India -- Bayer CropScience Ltd

Monsanto
Press Trust of India New Delhi
2 min read Last Updated : Sep 14 2019 | 9:37 AM IST

The National Company Law Tribunal (NCLT) on Friday approved the merger of biotech company Monsanto India Ltd with Bayer CropScience.

In June 2018, German chemical and pharma major Bayer AG had announced completion of the USD 63 billion mega-deal to acquire US-based biotech major Monsanto to create the world's biggest agro-chemical and seed company.

Bayer had in May received approval from the fair trade regulator Competition Commission of India (CCI), paving way for the completion of the global merger.

Bayer CropScience took shareholders' approval for the merger during the first quarter of 2019-20 and was waiting the final approval of the NCLT to make the global merger effective in India.

"...the Mumbai Bench of the NCLT has on September 13, 2019 conveyed its approval for the Scheme of Amalgamation of Monsanto India Ltd with Bayer CropScience Ltd and their respective shareholders, under sections 230 to 232 of the Companies Act, 2013," Bayer CropScience said in a regulatory filing.

The Scheme will become effective after the company files the certified copy of the NCLT order along with the amalgamation scheme with the Registrar of Companies.

Bayer Group is present in India since 1896 and has two divisions -- crop science and pharmaceutical. It has one listed entity in India -- Bayer CropScience Ltd.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Bayer MonsantoMonsanto BayerMonsanto IndiaBayer Cropscience Monsanto IndiaBayer-Monsanto merger

First Published: Sep 13 2019 | 10:30 PM IST

Next Story